Literature DB >> 9776472

Anti-Ri positive opsoclonus-myoclonus-ataxia in ovarian duct cancer.

J L Jongen, W J Moll, P A Sillevis Smitt, C J Vecht, C C Tijssen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9776472     DOI： 10.1007/s004150050270

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.

Authors:  Ashwani Kumar; Walter A Lajara-Nanson; Robert W Neilson
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

Review 2.  Acquired ataxias: the clinical spectrum, diagnosis and management.

Authors:  Wolfgang Nachbauer; Andreas Eigentler; Sylvia Boesch
Journal:  J Neurol       Date:  2015-03-26       Impact factor: 4.849

3.  Opsoclonus as a suspected paraneoplastic syndrome of endometrial cancer.

Authors:  Mark A Lewis; Lynn C Hartmann; Daniel H Lachance; Rafael E Jimenez
Journal:  Rare Tumors       Date:  2010-09-30

4.  Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature.

Authors:  Angelina Maria Martins Lino; Raphael Ribeiro Spera; Fernando Peixoto Ferraz de Campos; Christian Henrique de Andrade Freitas; Márcio Ricardo Taveira Garcia; Leonardo da Costa Lopes; Aleksander Snioka Prokopowitsch
Journal:  Autops Case Rep       Date:  2014-03-31

Review 5.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

6.  Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies.

Authors:  Claire Simard; Alberto Vogrig; Bastien Joubert; Sergio Muñiz-Castrillo; Géraldine Picard; Véronique Rogemond; François Ducray; Giulia Berzero; Dimitri Psimaras; Jean-Christophe Antoine; Virginie Desestret; Jérôme Honnorat
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.